
Guidelines for the Development of a National Programme for Haemophilia
Jointly produced by the WFH and WHO, this publication provides guidance on the development of a successful national care program
Year: 2023
Language: English
Author(s): World Federation of Hemophilia
Format: Document
This fact sheet contains commonly asked questions and more information on hemostatic rebalancing therapy.
Learn more about different treatment options for hemophilia with the World Federation of Hemophilia Shared Decision Making tool!
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

Jointly produced by the WFH and WHO, this publication provides guidance on the development of a successful national care program

This joint WFH/WHO report reviews those issues surrounding management of hemophilia and its complications.

Summarizes discussions and recommendations for the prevention and control of hemophilia made by participants at a joint WHO/WFH Meeting.